$Prolonged Survival Outcome in a Patient with Refractory Metastatic Colorectal Cancer Treated with Regorafenib Plus 5-Fluorouracil: A Case Report and Literature Review$
QR Code

QR Code

Prolonged Survival Outcome in a Patient with Refractory Metastatic Colorectal Cancer Treated with Regorafenib Plus 5-Fluorouracil: A Case Report and Literature Review

<b>Background:</b> The use of regorafenib and 5-fluorouracil in the management of refractory metastatic colorectal cancer has gained increasing attention due to their demonstrated efficacy in extending the survival of patients with colorectal cancer. This study aims to discuss the effect...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abdullah Esmail, Bayan Khasawneh, Ebtesam Al-Najjar, Raed Zaidan, Maen Abdelrahim
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Reports
Subjects:	colorectal cancer metastasis case report regorafenib 5-fluorouracil 5-FU
Online Access:	https://www.mdpi.com/2571-841X/8/2/59
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Kepingan Es Sebagai Cryotherapy untuk Mengobati Mukositis Pada Pasien Kanker Kolon Yang Menjalani Kemoterapi Regimen Fluorouracil (5FU)
by: Trisnowati Uji, et al.
Published: (2025-07-01)

PERBANDINGAN KEJADIAN LEUKOPENIA DAN TROMBOSITOPENIA PADA PENDERTIA KARSINOMA NASOFARING YANG MENDAPATKAN KEMOTERAPI PACLITAXEL CISPLATIN DAN CISPLATIN 5-FLUOROURACIL (5-FU)
by: Nadya Tara Audina, et al.
Published: (2019-10-01)

Shouhui Tongbian Capsule ameliorates 5-fluorouracil induced constipation in mice by modulating gut microbiota and activating PI3K/AKT/AQP3 signaling pathway
by: Yawei Zhang, et al.
Published: (2025-07-01)

Prognostic Factors Influencing the Efficacy of Regorafenib in the Treatment of Metastatic Colorectal Cancer
by: Nadiye SEVER, et al.
Published: (2025-06-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature
by: Tomoko Yoshimoto, et al.
Published: (2018-02-01)

Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5‐Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study
by: Ryosuke Kumanishi, et al.
Published: (2025-05-01)

Cardioprotective effects of dapagliflozin against the acute cardiotoxic effects of 5-fluorouracil
by: Mehmet Hakan Uzun, et al.
Published: (2025-07-01)

Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer
by: Leslie C. Cerpa, et al.
Published: (2025-07-01)

Effcacy and toxicity of regorafenib compared to reintrodaction of chemotherapy in metastatic colon cancer: retrospective multicenter study
by: E. S. Kuzmina, et al.
Published: (2023-09-01)

Dynamic of morphologic and morphometric changes in organs of immune system at fludinat and 5-fluorouracil administration
by: Grygorieva E.V.
Published: (2014-09-01)

ENCEPHALOPATHY AND HYPERLACTATEMIA AS A COMPLICATION OF 5-FLUOROURACIL TREATMENT
by: I. A. Kurmukov, et al.
Published: (2019-11-01)

Anticancer Efficacy of 5-Fluorouracil-Loaded Chitin Nanohydrogel in Enhanced Skin Cancer Therapy
by: Yuvraj D. Dange, et al.
Published: (2025-07-01)

Effect of 5-fluorouracil on Pseudomonas aeruginosa: impact on virulence, biofilm formation, and bacterial growth
by: Amani A. Niazy, et al.
Published: (2025-07-01)

Synergistic effect of regorafenib with aminoglycosides in ferroptosis-mediated liver injury
by: Maha Raja Dahar, et al.
Published: (2025-07-01)

Squamous cell carcinoma of the anus successfully treated with multidisciplinary therapy for metachronous metastatic and local recurrences after DCF chemotherapy: a case report
by: Ryozan Naito, et al.
Published: (2024-03-01)

Cure rate of low-risk superficial basal cell carcinoma treated with topical 5-fluorouracil
by: Camilo E Alarcón Pérez, et al.
Published: (2024-07-01)

Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids
by: Giulia Agostini, et al.
Published: (2025-07-01)

Development and Characterization of Optimized Drug-Loaded Niosomes for Delivery of 5-FU and Irinotecan
by: Kafilat O. Agbaje, et al.
Published: (2025-07-01)

An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance to NALIRIFOX: A Case Report and Literature Review
by: Bayan Khasawneh, et al.
Published: (2025-05-01)

ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy
by: Song L, et al.
Published: (2025-07-01)

Idiopathic Duodenal Hematoma: A Case Report and Literature Review
by: Ebtesam Al-Najjar, et al.
Published: (2025-05-01)

ITGA4 Contributes to 5-Fluorouracil Resistance by Up-Regulating PI3K/AKT Signaling: Evidence from Network Pharmacology, Molecular Docking and Experimental Verification
by: Yan S, et al.
Published: (2025-05-01)

USING CYTOSTATICS IN REFRACTORY GLAUCOMA SURGERY
by: T. A. Zhigalskaya, et al.
Published: (2018-10-01)

Benzodiazepine-conjugated pectin hydrogel beads: A controlled and targeted anticancer oral delivery system
by: Narges Zokaei Golestan, et al.
Published: (2025-09-01)

Quality by design enabled formulation development of regorafenib monohydrate loaded PEGylated PLGA polymeric nanoparticles: Enhanced oral bioavailability and biopharmaceutical attributes
by: Dhananjay Panigrahi, et al.
Published: (2024-10-01)

Synergistic Inhibition of Colorectal Cancer Growth by Qingjie Fuzheng Granule and 5-Fluorouracil through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway
by: Jin-Yan Zhao, et al.
Published: (2025-04-01)

Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs
by: Kevin Delgado-Calvo, et al.
Published: (2025-07-01)

Zuijiuquan (a drunkard's boxing) /
by: Ts'ai, Lung-yun
Published: (1986)

64 leg-attack methods of Shaolin kungfu /
by: Wang, Hsin-te
Published: (1986)

The Combination Effect of Chemotherapy Drug with Febuxostat and Curcumin on Colon Cancer Cell line (LS174T)
by: Ali M. Jaafar Abdulsahib, et al.
Published: (2025-04-01)

METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

STUDY OF THE DNA DAMAGE IN HeLa CELLS EXPOSED TO THE COMBINATION OF ULTRASOUND AND 5-FLUORURACYL
by: E. M. Frantsiyants, et al.
Published: (2019-11-01)

Investigation of the molecular and cellular effects of Shilajit on 5-fluorouracil (5-FU)-induced nephrotoxicity in rats
by: Mehmet Ezer, et al.
Published: (2025-05-01)

Study of polymorphisms of UGT1A1 and DPYD genes in chemotherapy for colorectal cancer
by: N. N. Timoshkina, et al.
Published: (2019-01-01)

Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients
by: Eman M. F. Barakat, et al.
Published: (2025-06-01)

Chinese martial arts : teach yourself.
Published: (1983)

Multi‐Targeted Kinase Inhibitor Therapy in Pediatric Bone and Soft Tissue Sarcoma Patients—A Single Centre Experience
by: Anna Mohás, et al.
Published: (2025-05-01)

Nano-erythrocyte membrane-chaperoned 5-fluorouracil liposomes as biomimetic delivery platforms to target hepatocellular carcinoma cell lines
by: Saeed A. AlQahtani, et al.
Published: (2019-12-01)

BRICS-Plus: the New Force in Global Governance
by: Ya. D. Lissovolik
Published: (2023-04-01)